Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Europe Breast Cancer Screening Analysis

5.1 Europe Breast Cancer Market
5.2 Europe Breast Cancer Population


6. Europe Breast Cancer Screening Population

6.1 Mammography Screening Population
6.2 MRI & Ultrasound Screening Population


7. Europe Breast Cancer Screening Market

7.1 Mammography Screening Market
7.2 MRI Screening Market
7.3 Ultrasound Screening Market


8. Population Share – Europe Breast Cancer Screening Analysis

8.1 By Country – Mammography Screening Population
8.2 By Country – MRI & Ultrasound Screening Population


9. Market Share – Europe Breast Cancer Screening Analysis

9.1 Breast Cancer Screening Market Share
9.2 Mammography Screening Market Share
9.3 MRI Screening Market Share
9.4 Ultrasound Screening Market Share


10. United Kingdom

10.1 United Kingdom Breast Cancer Mammography Screening Population
10.2 United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
10.3 United Kingdom Breast Cancer Screening Market

10.3.1 Mammography Screening Market
10.3.2 Magnetic Resonance Imaging (MRI) Screening Market
10.3.3 Ultrasound Screening Market


11. France

11.1 France Breast Cancer Mammography Screening Population
11.2 France Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
11.3 France Breast Cancer Screening Market

11.3.1 Mammography Screening Market
11.3.2 Magnetic Resonance Imaging (MRI) Screening Market
11.3.3 Ultrasound Screening Market


12. Germany

12.1 Germany Breast Cancer Mammography Screening Population
12.2 Germany Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
12.3 Germany Breast Cancer Screening Market

12.3.1 Mammography Screening Market
12.3.2 Magnetic Resonance Imaging (MRI) Screening Market
12.3.3 Ultrasound Screening Market


13. Italy

13.1 Italy Breast Cancer Mammography Screening Population
13.2 Italy Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
13.3 Italy Breast Cancer Screening Market

13.3.1 Mammography Screening Market
13.3.2 Magnetic Resonance Imaging (MRI) Screening Market
13.3.3 Ultrasound Screening Market


14. Spain

14.1 Spain Breast Cancer Mammography Screening Population
14.2 Spain Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
14.3 Spain Breast Cancer Screening Market

14.3.1 Mammography Screening Market
14.3.2 Magnetic Resonance Imaging (MRI) Screening Market
14.3.3 Ultrasound Screening Market & Forecast


15. Switzerland

15.1 Switzerland Breast Cancer Mammography Screening Population
15.2 Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
15.3 Switzerland Breast Cancer Screening Market

15.3.1 Mammography Screening Market
15.3.2 Magnetic Resonance Imaging (MRI) Screening Market
15.3.3 Ultrasound Screening Market


16. Norway

16.1 Norway Breast Cancer Mammography Screening Population
16.2 Norway Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
16.3 Norway Breast Cancer Screening Market

16.3.1 Mammography Screening Market
16.3.2 Magnetic Resonance Imaging (MRI) Screening Market
16.3.3 Ultrasound Screening Market


17. Netherlands

17.1 Netherlands Breast Cancer Mammography Screening Population
17.2 Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
17.3 Netherlands Breast Cancer Screening Market

17.3.1 Mammography Screening Market
17.3.2 Magnetic Resonance Imaging (MRI) Screening Market
17.3.3 Ultrasound Screening Market


18. Porters Five Forces

18.1 Overview
18.2 Bargaining Power of Buyers
18.3 Bargaining Power of Suppliers
18.4 Degree of Competition
18.5 Threat of New Entrants
18.6 Threat of Substitutes


19. Company Analysis

19.1 AstraZeneca

19.1.1 Overview
19.1.2 Recent Development
19.1.3 Sales Analysis

19.2 Novartis

19.2.1 Overview
19.2.2 Recent Development
19.2.3 Sales Analysis

19.3 Sanofi

19.3.1 Overview
19.3.2 Recent Development
19.3.3 Sales Analysis

19.4 Pfizer

19.4.1 Overview
19.4.2 Recent Development
19.4.3 Sales Analysis

19.5 Bayer AG

19.5.1 Overview
19.5.2 Recent Development
19.5.3 Sales Analysis

19.6 GlaxoSmithKline plc

19.6.1 Overview
19.6.2 Recent Development
19.6.3 Sales Analysis

19.7 Hoffmann-La Roche Ltd.

19.7.1 Overview
19.7.2 Recent Development
19.7.3 Sales Analysis

19.8 Sun Pharmaceutical Industries Ltd

19.8.1 Overview
19.8.2 Recent Development
19.8.3 Sales Analysis



List of Figures

Figure-01: Europe – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-02: Europe – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-03: Europe – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-04: Europe – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-05: Europe – Breast Cancer Screening Market (Million US$), 2017 – 2021
Figure-06: Europe – Forecast for Breast Cancer Screening Market (Million US$), 2022 – 2027
Figure-07: Europe – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-08: Europe – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-09: Europe – Breast Cancer MRI Screening Market (Million US$), 2017 – 2021
Figure-10: Europe – Forecast for Breast Cancer MRI Screening Market (Million US$), 2022 – 2027
Figure-11: Europe – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-12: Europe – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-13: United Kingdom – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-14: United Kingdom – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-15: United Kingdom – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-16: United Kingdom – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-17: United Kingdom – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-18: United Kingdom – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-19: United Kingdom – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-20: United Kingdom – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-21: United Kingdom – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-22: United Kingdom – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-23: France – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-24: France – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-25: France – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-26: France – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-27: France – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-28: France – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-29: France – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-30: France – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-31: France – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-32: France – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-33: Germany – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-34: Germany – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-35: Germany – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-36: Germany – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-37: Germany – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-38: Germany – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-39: Germany – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-40: Germany – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-41: Germany – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-42: Germany – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-43: Italy – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-44: Italy – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-45: Italy – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-46: Italy – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-47: Italy – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-48: Italy – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-49: Italy – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-50: Italy – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-51: Italy – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-52: Italy – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-53: Spain – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-54: Spain – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-55: Spain – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-56: Spain – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-57: Spain – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-58: Spain – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-59: Spain – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-60: Spain – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-61: Spain – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-62: Spain – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-63: Switzerland – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-64: Switzerland – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-65: Switzerland – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-66: Switzerland – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-67: Switzerland – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-68: Switzerland – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-69: Switzerland – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-70: Switzerland – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-71: Switzerland – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-72: Switzerland – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-73: Norway – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-74: Norway – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-75: Norway – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-76: Norway – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-77: Norway – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-78: Norway – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-79: Norway – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-80: Norway – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-81: Norway – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-82: Norway – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-83: Netherlands – Breast Cancer Mammography Screening Population (Thousand), 2017 – 2021
Figure-84: Netherlands – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-85: Netherlands – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2017 – 2021
Figure-86: Netherlands – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-87: Netherlands – Breast Cancer Mammography Screening Market (Million US$), 2017 – 2021
Figure-88: Netherlands – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-89: Netherlands – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2017 – 2021
Figure-90: Netherlands – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-91: Netherlands – Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2021
Figure-92: Netherlands – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-93: AstraZeneca – Global Revenue (Million US$), 2017 – 2021
Figure-94: AstraZeneca – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-95: Novartis – Global Revenue (Million US$), 2017 – 2021
Figure-96: Novartis – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-97: Sanofi – Global Revenue (Million US$), 2017 – 2021
Figure-98: Sanofi – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-99: Pfizer – Global Revenue (Million US$), 2017 – 2021
Figure-100: Pfizer – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-101: Bayer AG – Global Revenue (Million US$), 2017 – 2021
Figure-102: Bayer AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-103: GlaxoSmithKline plc – Global Revenue (Million US$), 2017 – 2021
Figure-104: GlaxoSmithKline plc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-105: Hoffmann-La Roche Ltd. – Global Revenue (Million US$), 2017 – 2021
Figure-106: Hoffmann-La Roche Ltd. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-107: Sun Pharmaceutical Industries Ltd – Global Revenue (Million US$), 2017 – 2021
Figure-108: Sun Pharmaceutical Industries Ltd – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Europe – Mammography Screening Population Share by Country (Percent), 2017 – 2021
Table-02: Europe – Forecast for Mammography Screening Population Share by Country (Percent), 2022 – 2027
Table-03: Europe – MRI & Ultrasound Screening Population Share by Country (Percent), 2017 – 2021
Table-04: Europe – Forecast for MRI & Ultrasound Screening Population Share by Country (Percent), 2022 – 2027
Table-05: Europe – Breast Cancer Screening Market Share by Country (Percent), 2017 – 2021
Table-06: Europe – Forecast for Breast Cancer Screening Market Share by Country (Percent), 2022 – 2027
Table-07: Europe – Mammography Screening Market Share by Country (Percent), 2017 – 2021
Table-08: Europe – Forecast for Mammography Screening Market Share by Country (Percent), 2022 – 2027
Table-09: Europe – MRI Screening Market Share by Country (Percent), 2017 – 2021
Table-10: Europe – Forecast for MRI Screening Market Share by Country (Percent), 2022 – 2027
Table-11: Europe – Ultrasound Screening Market Share by Country (Percent), 2017 – 2021
Table-12: Europe – Forecast for Ultrasound Screening Market Share by Country (Percent), 2022 – 2027